Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning

Overview of attention for article published in Experimental Hematology & Oncology, July 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 1 X user

patent: 37 patents

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease

Article in Cytotherapy (September 2023)

Hypothesis: can transfer of primary neoplasm-derived extracellular vesicles and mitochondria contribute to the development of donor cell–derived hematologic neoplasms after allogeneic hematopoietic cell transplantation?

Article in Cytotherapy (September 2022)

Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults

Article in Cytotherapy (May 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.